On Monday, Regenxbio Inc (NASDAQ: RGNX) opened higher 3.58% from the last session, before settling in for the closing price of $11.16. Price fluctuations for RGNX have ranged from $8.53 to $28.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 72.63% over the last five years. Company’s average yearly earnings per share was noted 20.37% at the time writing. With a float of $44.62 million, this company’s outstanding shares have now reached $49.55 million.
The firm has a total of 344 workers. Let’s measure their productivity. In terms of profitability, gross margin is 39.46%, operating margin of -289.09%, and the pretax margin is -283.37%.
Regenxbio Inc (RGNX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Regenxbio Inc is 9.95%, while institutional ownership is 86.74%. The most recent insider transaction that took place on Oct 01 ’24, was worth 101,052. In this transaction Director of this company sold 10,000 shares at a rate of $10.11, taking the stock ownership to the 11,286 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Director sold 10,000 for $11.56, making the entire transaction worth $115,588. This insider now owns 11,286 shares in total.
Regenxbio Inc (RGNX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 20.37% per share during the next fiscal year.
Regenxbio Inc (NASDAQ: RGNX) Trading Performance Indicators
Check out the current performance indicators for Regenxbio Inc (RGNX). In the past quarter, the stock posted a quick ratio of 3.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.03, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Regenxbio Inc (RGNX)
Analysing the last 5-days average volume posted by the [Regenxbio Inc, RGNX], we can find that recorded value of 0.92 million was better than the volume posted last year of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 83.70%. Additionally, its Average True Range was 0.70.
During the past 100 days, Regenxbio Inc’s (RGNX) raw stochastic average was set at 44.32%, which indicates a significant decrease from 82.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.77% in the past 14 days, which was higher than the 65.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.57, while its 200-day Moving Average is $14.36. Now, the first resistance to watch is $12.09. This is followed by the second major resistance level at $12.62. The third major resistance level sits at $13.02. If the price goes on to break the first support level at $11.16, it is likely to go to the next support level at $10.76. Now, if the price goes above the second support level, the third support stands at $10.23.
Regenxbio Inc (NASDAQ: RGNX) Key Stats
There are currently 49,545K shares outstanding in the company with a market cap of 571.20 million. Presently, the company’s annual sales total 90,240 K according to its annual income of -263,490 K. Last quarter, the company’s sales amounted to 22,300 K and its income totaled -52,990 K.
